Understanding antibiotic resistance and microbiome changes in STI prevention
Official title: STI Prophylaxis and Emergence of Antimicrobial Resistance
Run by University College, London · NCT06778083 · Data updated 2026-11-12
This study is trying to see how using doxycycline for STI prevention affects antibiotic resistance and changes in gut bacteria in men who have sex with men.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Men only |
| Enrollment | 108 (estimated) |
| Sponsor | University College, London Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | February 10, 2025 |
| Main results expected | April 30, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | March 27, 2025 |
| Trial ID | NCT06778083 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are men aged 18 and older who identify as cis or trans and have sex with men.
✕Probably not a fit
Patients currently being treated for an STI or those who have used antibiotics other than doxycycline in the past three months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the risk of antibiotic resistance and alterations in the human microbiome associated with the use of doxycycline for STI prophylaxis among men who have sex with men (MSM). The study will recruit 108 participants, both users and non-users of STI prophylaxis, who will provide throat swabs and stool samples every six months. These samples will be analyzed for bacterial DNA to identify species present and assess antibiotic resistance. Additionally, participants will complete questionnaires to evaluate the acceptability of the prophylaxis approach.
Why it matters
Potential benefit: If successful, this study could provide insights into the safety and effectiveness of using doxycycline for STI prevention, potentially leading to better public health strategies.
How similar studies have gone: While the approach of assessing antibiotic resistance in relation to STI prophylaxis is relatively novel, similar studies have explored antibiotic use and resistance, indicating potential for valuable findings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged ≥ 18 years. * Identifies as a man (cis or trans). * Has sex with men. * Able to provide informed consent. Exclusion Criteria: * Use of an antibiotic other than doxycycline in the 3 months prior to enrolment * Currently being treated for an STI with doxycycline * Use of doxycycline within the prior 3 months for an indication other than STI treatment or STI prevention.
Where it's running
-
Central and North West London NHS Foundation Trust
London, United Kingdom Recruiting
Study contacts
- Study coordinator: Manik Kohli, MBChB MSc
- Email: m.kohli@ucl.ac.uk
- Phone: +4420276794466
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Which single-dose antibiotic works best to prevent complications after lower wisdom tooth removal
This trial tests whether a single dose of amoxicillin, clindamycin, or azithromycin is best at reducing post-surgery problems for adults undergoing lower wisdom tooth extraction.
-
Piperacillin Prophylaxis in Major Liver and Pancreatic Surgery
This study tests whether piperacillin/tazobactam given around surgery reliably reaches the right levels to help prevent infections in adults undergoing major liver or pancreatic surgery.
-
Antibiotic Prophylaxis Before Simple Tooth Extraction in Immunosuppressed Patients with Autoimmune Rheumatic Diseases
This trial tests whether giving a single dose of amoxicillin before a simple tooth extraction can prevent infections in adults with autoimmune rheumatic diseases who are on immunosuppressive therapy.
-
Adding azithromycin to ampicillin for late PPROM
This test sees if adding a single dose of azithromycin to the usual ampicillin/amoxicillin treatment helps newborns when membranes break early between 34.0 and 36.6 weeks.
-
Cefazolin Prophylaxis and CSF Levels in Ventricular Shunt Surgery
This study tests whether a standard 2 g dose of cefazolin given before ventricular shunt surgery yields enough drug in the brain’s fluid to help prevent valve infections.
-
Testing targeted antibiotics to prevent infections after bladder surgery
This study is testing if using personalized antibiotics based on urine bacteria can help prevent infections after bladder surgery better than standard antibiotics.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.